Ebos 1Q trading up 10%, new CEO Davies says

Ebos 1Q trading up 10%, new CEO Davies says
By Paul McBeth Oct. 31 (BusinessDesk) - Ebos Group, the healthcare and animal care products company, is tracking ahead of last year in the first three months of trading, as it beds in a much bigger focus in Australia after its 2013 acquisition of pharmaceutical firm Symbion. The Christchurch-based company's first-quarter trading was 10 percent ahead of the same period a year earlier, new chief executive Patrick Davies told shareholders at today's annual meeting, without being more specific. He also told them of today's acquisition of Aust...